«IN VITRO» AND «IN VIVO» INHIBITORY EFFECT OF COPPER SULPHATE UPON THE ACTIVITY OF BLOOD CATALASE by Yordanova, E.
I 
« I N VITRO» AND «IN VIVO» INHIBITORY E F F E C T 
OF COPPER S U L P H A T E UPON T H E ACTIVITY 
OF BLOOD C A T A L A S E 
E . Yordanova 
Catalase represents a metalloenzyme, hemo-protein w i t h 250 000 mole­
cular weight. Ferriprotoporphyrin 9 (type 3) forms its prosthetic group, 
containing trivalent iron which never alters its valency during enzyme reac­
t ion. Catalase is the most active of a l l enzymes hitherto known. A single 
catalase molecule decomposes 5 000 000 hydrogen peroxide molecules per 
minute at temperature 0° С and p H = 6 . 6 . 
T h e biological role of the enzyme consists in spl itt ing and el imination 
of toxic hydrogen peroxide, produced during metabolic processes in the 
human organism (2, 6 ) . 
Numerous and rather different mechanisms exist through which the 
organism regulates the a c t i v i t y of its enzymes. I n principle, such a regu­
lation is manifested either by enhancing the enzyme a c t i v i t y by means of 
various substances denominated activators, or by suppressing it by means 
of inhibitors, acting upon the enzyme reactions under adequate conditions 
( 3 , 4 , 5, 6, 7, 8 ) . The problem of enzyme a c t i v i t y inhibition is very impor­
tant and is subject to numerous up-to-date biochemical and enzymologi-
cal studies. 
A number of inhibitors of the catalase a c t i v i t y are known — m a i n l y 
metal ions — w h i c h react w i t h the iron in the prosthetic group of the en­
zyme (1) . 
T a k i n g into consideration the circumstance of the frequently occurring 
iron metabolism disorders in systemic blood affections and the fact that 
catalase is an iron-containing enzyme, playing an essential role in redox 
reaction processes of the human organism, we set out to investigate the 
inhibitory effect of copper sulphate, exerted upon the a c t i v i t y of erythro­
cyte catalase under «in vitro» and «in vivo» conditions. 
Material and Methods 
«In vitro» studies were performed on twenty healthy individuals . Cata­
lase a c t i v i t y of the blood in the course of the experiment was determined 
repeatedly, namely: a) before the influence of copper sulphate — i n i t i a l 
value of the enzyme, and b) threefold investigation following treatment 
of the blood w i t h 0 . 1 , 0.5 and 1% water solution of copper sulphate. T h e 
concentrations mentioned above were obtained by the addition of 10, 50 
and 100 mg copper sulphate substance to a determined standard solution 
with the purpose to preserve unaltered its constituents' rat io . 
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«In vivo» studies were conducted on twenty-one practical ly healthy sub­
jects under the following experimental setting: a) determination of the i n i ­
t ia l catalase a c t i v i t y ; b) administration per os of 1 % water solution of cop­
per sulphate over a period of seven days, 3.5 m l dai ly , at weekly dose 0.6 mg 
per kilogram body weight; c) re-examination of the blood catalase at 2 hours, 
3 , 7 and 12 days after cessation of copper sulphate application. The periods 
of investigation indicated above were a r b i t r a r i l y selected to the end of 
obtaining a better idea about the duration of the enzyme's a c t i v i t y inhi­
bition and recovery. 
Catalase investigation was carried out after the titration method of 
B a c h and Zubkova. 
I n both experimental settings, also the catalase number and the cata­
lase index were investigated (catalase a c t i v i t y of 10 6 erythrocytes). T h e 
catalase index was determined on the basis of the number of erythrocytes, 
as w e l l as on the basis of the venous hematocrit in part of the examinees. 
Results and Discussion 
I n the ten parallel investigations on the a c t i v i t y of blood catalase per­
formed in one and the same subject, a very good reproducibility of data 
was established. The mean catalase index was 4 . 5 + 0 . 0 7 , whereas the mean 
catalase number — 1 5 . 0 + 0 . 0 5 . T h e latter data confirm the r e l i a b i l i t y of 
the method employed. 
I . Results from Investigations «in Vitro» 
The starting mean value of the catalase index was normal: 3 . 9 ± 0 . 0 7 
(ranging from 3.5 to 4 . 6 ) . I t was used as a standard value in the assessment 
of the data obtained after influencing the enzyme reaction w i t h copper 
sulphate. After addition of the smallest copper sulphate amount employed 
(10 mg), a substantial inhibition of the catalase a c t i v i t y occurred. The mean 
catalase index was lowered more than two times as compared to the start­
ing one, reaching the values 1 .5+0.06 . Upon treatment w i t h copper-sul­
phate dose exceeding 50 mg, the degree of enzyme inhibition was intensi­
fied. The mean catalase index reached up to 1.0 + 0.06, i . e. a value three 
times lower than the starting one. Maximal enzyme a c t i v i t y inhibit ion was 
recorded after treatment w i t h the highest concentration — 100 mg copper 
sulphate (1 % ) at which the mean catalase index reached its lowest value — 
0 . 4 + 0 . 0 4 . The attempts to use s t i l l higher concentrations of the inhibitor 
( 3 % ) failed, owing to the fact that very low values of the catalase number 
were produced, rendering rather difficult its recording. 
The data submitted corroborate in an indisputable manner the power­
ful inhibitory effect of copper sulphate on the blood catalase a c t i v i t y «in 
vitro». T h e inhibition of the enzyme a c t i v i t y was manifested in a l l concen­
trations employed in the experiment, and rised in proportion to the concen­
tration of the inhibitor. The latter dependence between copper sulphate 
and enzyme a c t i v i t y is presented in Diagram 1. 
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Diagr. 1 
T h e statistical elaboration, performed after the method of variat ional 
analysis , reveals a great r e l i a b i l i t y of the results between the different set­
tings of the experiment «in vitro» ( P < 0 . 0 0 1 ) . 
I I . Results from Investigations «in Vivo» 
Peroral application of copper sulphate was carried out in compliance 
w i t h its routinely adopted therapeutical dosage. 
T h e mean starting value of t h e c a t a k s e index was normal — 4 . 3 + 0 . 3 1 
(ranging from 3.5 to 5 .5) . After 7-day application of copper sulphate, the 
catalase a c t i v i t y was re l iably lowered ( P < 0 . 0 0 5 ) , while the mean catalase 
index reached 3 . 0 + 0 . 1 7 . T h e latter value refers to investigation of catalase, 
carried out at 2 hours from the last administration of the inhibitor. Despite 
the cessation of copper sulphate, the a c t i v i t y of catalase progressively di­
minished and at 3 days, the enzyme a c t i v i t y reached its m a x i m a l inhibi­
t ion. T h e mean catalase a c t i v i t y was lowered three times, as compared to 
the starting one (mean value 1.6 + 0.41). A t 7 days, reduction of the cata­
lase a c t i v i t y inhibition was established, which began restoration, however, 
without reaching ful l normalization ( P > 0 . 0 5 ) . The mean catalase a c t i v i t y 
rised up to 3 . 4 + 0 . 2 9 . O n l y at 12 days after discontinuing copper sulphate 
application, the catalase a c t i v i t y showed ful l normalization and reached 
its starting level (mean catalase index — 4 . 0 + 0 . 2 2 ) ( P < 0 . 0 5 ) . 
Diagram 2 illustrates the results of the investigations «in vivo». 
The analysis of the concrete data concerning the different subjects in­
vestigated demonstrate that catalase a c t i v i t y inhibition during experi­
ments «in v ivo* runs a course m a i n l y in tw direoctions, namely: 
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Diagr. 2 
1) M a x i m u m inhibition of the enzyme a c t i v i t y occurs at 3 days after discon­
tinuing the effect of the inhibitor , proved in 15 cases of the series under 
investigation ( 7 1 . 5 % ) . A t 12 days, the inhibitory effect of copper sulphate 
was already absent in them and the enzyme a c t i v i t y disclosed ful l normali­
zation. Such a regularity lends itself to graphic expression, as i l lustrated i n 
Scheme 1 . 
2) M a x i m u m inhibition of the enzyme a c t i v i t y occurs later — at 7 days 
after discontinuation of copper sulphate — disclosed by five of the exa­
minees ( 2 3 . 8 % ) . I n the latter group, the catalase a c t i v i t y was normalized 
s i m i l a r l y at 12 days. G r a p h i c a l l y expressed, this pattern of inhibit ion is 
i l lustrated in Scheme 2. 
There is a single exception of the two basic patterns of inhibit ion describ­
ed above ( 4 . 7 % ) . I t concerns a case in which a rather prolonged inhibit ion 
of enzyme a c t i v i t y was recorded, w i t h normalization occurring not earlier 
than the 20th day after the stopping of copper sulphate. 
I n two cases of the series, catalase a c t i v i t y was traced d a i l y , over a 
period of 12 days subsequent to the cessation of copper sulphate applica­
tion, in order to mark the t ime, by days, of the enzyme inhibit ion. I n accor­
dance w i t h the regularity outlined, in the latter two cases, catalase acti­
v i t y inhibit ion w i t h an identical 10—12 days duration was likewise estab­
lished. 
Furthermore, the summarized and specific data from the experi­
ments «in vivo» confirm the inhibitory effect of copper sulphate, being 
manifested after 7-day-long application and persisting for about 10—12 
days after its discontinuation. 
The comparative study of the degree of enzyme inhibition, after exert­
ing effect w i t h the highest concentration of 100 mg, respectively 1 % water 
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Scheme 2 
solution of copper sulphate, «in vivo» and «in vitro», in ten of the subjects 
under investigation, shows inhibit ion «in vitro» two times stronger than 
«in vivo». Such differences in the two experimental settings are logical , 
since the conditions under which the inhibitor exerts its effect are likewise 
principal ly different. 
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Discussion 
The data from the investigations «in vitro», and «in vivo» submitted 
in the paper are mono-directional and corroborate the inhibitory effect 
of copper sulphate exerted on blood catalase a c t i v i t y . I t should be stressed 
that a l l the concentrations of copper sulphate employed by us in the expe­
rimental setting «in vitro», the lowest comprised, suppress the enzyme ac­
t i v i t y , w i t h the degree of inhibit ion being directly proportional to the con­
centration of the inhibitor. 
The data recovered from the experimental setting «in vivo» s i m i l a r l y 
corroborate the inhibitory action of copper sulphate. The m a x i m u m inhi­
bitory effect in the latter case occurs in the period ranging from 3 to 7 days after 
the cessation of copper sulphate. The a c t i v i t y of the enzyme is f u l l y re­
stored at 12 days. The data of the «in vivo»„ studies show that in this 
particular instance, a process of reversible enzyme inhibition takes place, 
w i t h duration of the inhibitory effect about 12 days w i t h ensuing ful l nor­
malization of catalase a c t i v i t y . T h i s finding of ours may have certain prac­
tical bearing upon the therapeutical use of copper sulphate in certain 
conditions of anemia, due to copper sulphate. On the basis of the results 
obtained, it might be presumed that the continuous therapeutical appl i ­
cation of copper sulphate would produce also a prolonged inhibit ion of 
the a c t i v i t y of such an important enzyme as the catalase. Bearing in mind 
the facts listed above, it appears logical to assume that short-term thera­
peutical courses w i t h copper sulphate, followed by rest intervals during 
which restoration of the enzyme a c t i v i t y would take place, should be con­
sidered much more expedient. 
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И Н Г И Б И Т О Р Н О Е Д Е Й С Т В И Е С Е Р Н О К И С Л О Й М Е Д И 
НА А К Т И В Н О С Т Ь К А Т А Л А З Ы К Р О В И IN VITRO И IN VIVO 
Евг. Йорданова 
Р Е З Ю М Е 
Изучили ингибирующее действие сернокислой меди на активность 
каталазы крови in v i tro и in v i v o . Установили, что в обеих опытных по­
становках сернокислая медь ингибирует активность энзима. Ингибиция 
выражена очень сильно в опытной постановке in v i tro; ее степень прямо 
пропорциональна концентрации сернокислой меди. 
В исследованиях in v i v o установили более слабое ингибирующее дей­
ствие сернокислой меди, достигающее максимума на 3-й и на 7-й день 
со дня удаления ингибитора. Через 12 дней ингибирующего энзимного 
действия сернокислой меди наступает нормализация в активности ката­
лазы, что говорит об обратимости энзимной ингибиции. 
Исходя из полученных данных, автор делает практический вывод 
в связи с осторожным терапевтическим применением сернокислой меди, 
поскольку продолжительное его применение вызовет и более продол­
жительную ингибицию такого важного энзима как каталазу. 
